These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8256637)

  • 1. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Fux M; Taub M; Zohar J
    Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abrupt discontinuation of fluvoxamine in patients with panic disorder.
    Black DW; Wesner R; Gabel J
    J Clin Psychiatry; 1993 Apr; 54(4):146-9. PubMed ID: 8486592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R; McLeod DR; Hipsley PA
    J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
    Goddard AW; Woods SW; Sholomskas DE; Goodman WK; Charney DS; Heninger GR
    Psychiatry Res; 1993 Aug; 48(2):119-33. PubMed ID: 8416022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D; Bullock T; Montgomery D; Montgomery S
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A; Grosso S; Poli P
    Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N; Terao T; Ohmori O; Nakamura J
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
    Vandel S; Bertschy G; Baumann P; Bouquet S; Bonin B; Francois T; Sechter D; Bizouard P
    Pharmacol Res; 1995 Jun; 31(6):347-53. PubMed ID: 8685072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apathy and indifference in patients on fluvoxamine and fluoxetine.
    Hoehn-Saric R; Lipsey JR; McLeod DR
    J Clin Psychopharmacol; 1990 Oct; 10(5):343-5. PubMed ID: 2124218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute treatment response in outpatients with panic disorder: high versus low depressive symptoms.
    Black DW; Wesner R; Bowers W; Monahan P; Gabel J
    Ann Clin Psychiatry; 1995 Dec; 7(4):181-8. PubMed ID: 8721892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients.
    Strik JJ; Honig A; Lousberg R; Cheriex EC; Van Praag HM
    Int Clin Psychopharmacol; 1998 Nov; 13(6):263-7. PubMed ID: 9861576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF
    J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
    Mann JJ; Kapur S
    Arch Gen Psychiatry; 1991 Nov; 48(11):1027-33. PubMed ID: 1747018
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
    van Vliet IM; den Boer JA; Westenberg HG; Slaap BR
    J Clin Psychopharmacol; 1996 Aug; 16(4):299-306. PubMed ID: 8835705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.